ELOCTATE- antihemophilic factor (recombinant), fc fusion protein
Biogen Idec Inc.
1 INDICATIONS AND USAGE
ELOCTATE, Antihemophilic Factor (Recombinant), Fc Fusion Protein, is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for:
Control and prevention of bleeding episodes,
Perioperative management (surgical prophylaxis),
Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
ELOCTATE is not indicated for the treatment of von Willebrand disease.